Marker Therapeutics (MRKR) vs NewcelX (NCEL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed NewcelX (NCEL) over the past year, losing 1.9% versus a loss of 83.4%. Over five years, MRKR leads with a -93.5% price change compared with -99.7% for NCEL. NewcelX is the larger company by market cap ($18.0 million vs $16.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MRKR | NCEL |
|---|---|---|
| Share price | $0.965 | $3.11 |
| Market cap | $16.09M | $17.96M |
| 1-day change | -7.31% | +2.47% |
| YTD return | -30.20% | +59.74% |
| 1-year return | -1.89% | -83.42% |
| 5-year return | -93.46% | -99.69% |
| P/E ratio (TTM) | — | 5.98 |
| EPS (TTM) | $-0.42 | $0.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.46 | $19.07 |
| 52-week low | $0.84 | $1.83 |
| Distance from 52-week high | -60.77% | -83.69% |
| Average volume | 64.80K | 12.22K |
| Shares outstanding | 16.67M | 5.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed NCEL by 81.5 percentage points over the past year.
MRKR vs NCEL FAQ
Which is bigger, Marker Therapeutics or NewcelX?
NewcelX (NCEL) is larger, with a market capitalization of $17.96M compared with $16.09M for Marker Therapeutics (MRKR).
Which stock has performed better over the past year, MRKR or NCEL?
MRKR returned -1.89% over the past 12 months, compared with -83.42% for NCEL (price return, excluding dividends). Past performance does not predict future results.
Are Marker Therapeutics and NewcelX in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.